Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2002 2
2003 2
2004 6
2005 17
2006 19
2007 28
2008 56
2009 91
2010 4
2011 1
2012 5
2013 6
2014 4
2015 2
2016 3
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19562715

236 results
Results by year
Filters applied: . Clear all
Page 1
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD. Cescon M, et al. Liver Transpl. 2009 Jul;15(7):782-9. doi: 10.1002/lt.21760. Liver Transpl. 2009. PMID: 19562715 Free article.
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
Sharma P, Marrero JA, Fontana RJ, Greenson JK, Conjeevaram H, Su GL, Askari F, Sullivan P, Lok AS. Sharma P, et al. Liver Transpl. 2007 Aug;13(8):1100-8. doi: 10.1002/lt.21121. Liver Transpl. 2007. PMID: 17377914 Free article.
Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH. Raziorrouh B, et al. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):778-83. doi: 10.1097/MEG.0b013e3282f762f8. Eur J Gastroenterol Hepatol. 2008. PMID: 18617783
Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
Berenguer M, Aguilera V, Prieto M, Ortiz C, Rodríguez M, Gentili F, Risalde B, Rubin A, Cañada R, Palau A, Rayón JM. Berenguer M, et al. Liver Transpl. 2009 Jul;15(7):738-46. doi: 10.1002/lt.21707. Liver Transpl. 2009. PMID: 19562707 Free article.
Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D. Roche B, et al. Liver Transpl. 2008 Dec;14(12):1766-77. doi: 10.1002/lt.21635. Liver Transpl. 2008. PMID: 19025933 Free article.
Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R. Sánchez-Pérez B, et al. Transplant Proc. 2008 Nov;40(9):2994-6. doi: 10.1016/j.transproceed.2008.08.116. Transplant Proc. 2008. PMID: 19010171
Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial.
El-Hamamsy M, Montasser IF, Mansy AE, Nabet DE, El-Meteini M. El-Hamamsy M, et al. J Clin Pharm Ther. 2019 Jun;44(3):447-453. doi: 10.1111/jcpt.12807. Epub 2019 Feb 3. J Clin Pharm Ther. 2019. PMID: 30714175
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
Fernández I, Ulloa E, Colina F, Abradelo M, Jiménez C, Gimeno A, Meneu JC, Lumbreras C, Solís-Herruzo JA, Moreno E. Fernández I, et al. Liver Transpl. 2009 Aug;15(8):948-55. doi: 10.1002/lt.21780. Liver Transpl. 2009. PMID: 19642125 Free article.
Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J. Aguilera V, et al. Liver Transpl. 2009 Jan;15(1):79-87. doi: 10.1002/lt.21626. Liver Transpl. 2009. PMID: 19109849 Free article.
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.
Berenguer M, Palau A, Fernandez A, Benlloch S, Aguilera V, Prieto M, Rayón JM, Berenguer J. Berenguer M, et al. Liver Transpl. 2006 Jul;12(7):1067-76. doi: 10.1002/lt.20737. Liver Transpl. 2006. PMID: 16622844 Free article.
236 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback